Archford Capital Strategies, LLC Eli Lilly & CO Transaction History

Archford Capital Strategies, LLC

  • $681 Million
  • Q3 2024

A detailed history of Archford Capital Strategies, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Archford Capital Strategies, LLC holds 4,084 shares of LLY stock, worth $3.25 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares
4,084
Previous 4,051 0.81%
Holding current value
$3.25 Million
Previous $3.67 Million 1.34%
% of portfolio
0.53%
Previous 0.6%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024
BUY
$772.14 - $960.02 $25,480 - $31,680
33 Added 0.81%
4,084 $3.62 Million
Q2 2024

Jul 17, 2024
SELL
$724.87 - $909.04 $159,471 - $199,988
-220 Reduced 5.15%
4,051 $3.67 Million
Q1 2024

Apr 24, 2024
BUY
$592.2 - $792.28 $103,042 - $137,856
174 Added 4.25%
4,271 $3.32 Million
Q4 2023

Jan 12, 2024
SELL
$525.19 - $619.13 $245,263 - $289,133
-467 Reduced 10.23%
4,097 $2.39 Million
Q3 2023

Oct 27, 2023
BUY
$434.7 - $599.3 $15,649 - $21,574
36 Added 0.8%
4,564 $2.45 Million
Q2 2023

Aug 02, 2023
BUY
$350.74 - $468.98 $46,297 - $61,905
132 Added 3.0%
4,528 $2.12 Million
Q1 2023

Apr 18, 2023
BUY
$310.63 - $364.82 $147,549 - $173,289
475 Added 12.11%
4,396 $1.51 Million
Q4 2022

Jan 26, 2023
BUY
$321.55 - $374.67 $161,418 - $188,084
502 Added 14.68%
3,921 $0
Q3 2022

Oct 17, 2022
BUY
$296.48 - $337.87 $74,120 - $84,467
250 Added 7.89%
3,419 $1.11 Million
Q2 2022

Jul 12, 2022
BUY
$278.73 - $327.27 $61,041 - $71,672
219 Added 7.42%
3,169 $1.03 Million
Q1 2022

Apr 18, 2022
BUY
$234.69 - $291.66 $76,274 - $94,789
325 Added 12.38%
2,950 $863,000
Q4 2021

Jan 20, 2022
BUY
$224.85 - $279.04 $14,165 - $17,579
63 Added 2.46%
2,625 $725,000
Q3 2021

Oct 14, 2021
BUY
$221.6 - $272.71 $37,007 - $45,542
167 Added 6.97%
2,562 $592,000
Q2 2021

Jul 23, 2021
BUY
$180.55 - $233.54 $10,471 - $13,545
58 Added 2.48%
2,395 $550,000
Q1 2021

Apr 26, 2021
SELL
$164.32 - $212.72 $1.14 Million - $1.48 Million
-6,938 Reduced 74.8%
2,337 $434,000
Q4 2020

Jan 19, 2021
SELL
$130.46 - $172.63 $3,261 - $4,315
-25 Reduced 0.27%
9,275 $1.54 Million
Q3 2020

Oct 19, 2020
SELL
$146.22 - $169.13 $17,985 - $20,802
-123 Reduced 1.31%
9,300 $1.38 Million
Q2 2020

Jul 24, 2020
SELL
$136.42 - $164.18 $5,593 - $6,731
-41 Reduced 0.43%
9,423 $1.55 Million
Q1 2020

Apr 29, 2020
BUY
$119.05 - $147.35 $206,432 - $255,504
1,734 Added 22.43%
9,464 $1.31 Million
Q3 2019

Oct 23, 2019
SELL
$106.79 - $116.16 $2,135 - $2,323
-20 Reduced 0.26%
7,730 $864,000
Q2 2019

Jul 18, 2019
SELL
$110.79 - $129.32 $6,093 - $7,112
-55 Reduced 0.7%
7,750 $859,000
Q1 2019

May 13, 2019
SELL
$111.31 - $131.02 $33,393 - $39,306
-300 Reduced 3.7%
7,805 $1.01 Million
Q4 2018

Feb 13, 2019
SELL
$105.9 - $118.64 $3,177 - $3,559
-30 Reduced 0.37%
8,105 $938,000
Q3 2018

Nov 14, 2018
SELL
$85.86 - $107.31 $102,345 - $127,913
-1,192 Reduced 12.78%
8,135 $873,000
Q2 2018

Aug 14, 2018
BUY
$75.7 - $86.88 $706,053 - $810,329
9,327 New
9,327 $796,000
Q1 2018

May 14, 2018
SELL
$74.21 - $87.6 $474,943 - $560,640
-6,400 Closed
0 $0
Q4 2017

Feb 16, 2018
SELL
$81.94 - $87.89 $137,331 - $147,303
-1,676 Reduced 20.75%
6,400 $541,000
Q3 2017

Nov 17, 2017
BUY
$77.07 - $85.54 $129,169 - $143,365
1,676 Added 26.19%
8,076 $690,000
Q2 2017

Aug 25, 2017
BUY
N/A
4,612 Added 257.94%
6,400 $527,000
Q2 2017

Aug 18, 2017
BUY
N/A
1,788
1,788 $148,000

Others Institutions Holding LLY

# of Institutions
4,011
Shares Held
751M
Call Options Held
8.27M
Put Options Held
10.5M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Archford Capital Strategies, LLC Portfolio

Follow Archford Capital Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Archford Capital Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Archford Capital Strategies, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email